Table 3.
Survivors (N = 287) |
In-hospital death (N = 28) |
P | P * | |
---|---|---|---|---|
Age | 66.4 ± 15.8 | 68.5 ± 16.7 | 0.509 | — |
Male | 156 (49.5%) | 15 (4.8%) | 0.555 | — |
Smoking | 44 (14%) | 4 (1.3%) | 0.904 | — |
Hypertension | 194 (61.6%) | 22 (7%) | 0.361 | — |
Obesity | 23 (7.3%) | 4 (12.7%) | 0.498 | — |
Family history | 20 (6.3%) | 2 (0.6%) | 0.001 | — |
Diabetes | 107 (34%) | 9 (2.8%) | 0.652 | — |
Previous stroke | 75 (23.8%) | 9 (2.8%) | 0.189 | — |
Weakness and numbness | 192 (60.9%) | 19 (6%) | 0.179 | — |
Confusion, speech difficulties, and comprehension problems | 111 (35.2%) | 10 (3.2%) | 0.121 | — |
Vision abnormalities | 27 (8.6%) | 7 (2.2%) | 0.024 | 0.018 |
Walking troubles | 47 (14.9%) | 5 (1.6%) | 0.072 | — |
Severe headache | 48 (15.2%) | 7 (2.2%) | 0.135 | — |
Dizziness and incoordination | 60 (19%) | 5 (15.9%) | 0.064 | — |
CT detectable brain infarct | 56 (17.8%) | 7 (2.2%) | 0.538 | — |
CT dense artery sign | 13 (4.1%) | 3 (0.9%) | 0.005 | 0.599 |
Cerebral edema | 18 (5.7%) | 2 (0.6%) | 0.002 | 1.000 |
Wake-up stroke | 78 (24.8%) | 4 (1.3%) | 0.282 | — |
SBP | 150.2 ± 58 | 142.1 ± 24.7 | 0.165 | — |
DBP | 84.8 ± 46.2 | 81.8 ± 15.6 | 0.463 | — |
HR | 80.7 ± 15.8 | 78.2 ± 19.5 | 0.516 | — |
Sat O2 | 95.8 ± 3.2 | 96.5 ± 2.4 | 0.180 | — |
Temperature | 35.9 ± 3.1 | 36 ± 0.4 | 0.460 | — |
Digital glycemia | 136.6 ± 55 | 122 ± 33.9 | 0.100 | — |
Time of symptoms | 1777.7 ± 4215.2 | 773.25 ± 1180.7 | 0.009 | 0.252 |
Glasgow (initial) | 5.4 ± 7.5 | 6 ± 7.6 | 0.685 | 0.293 |
NIHSS (initial) | Median = 2, IR = 8 | Median = 2, IR = 10 | 0.694 | 0.125 |
CT: computed tomography; SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; Sat O2: oxygen saturation; NIHSS: National Institutes of Health Stroke Scale; IR = interquartile range; P: according to t-test (continuous variables) or Chi-square test (categorical variables); P *: according to binary logistic regression analysis with significant variables.